Oropharynx Cancer

Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Collagen Matrix in Oral Cancer Surgery

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

Study of Lymphatic Drainage Mapping in Oropharyngeal Cancers

Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?

Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer